Mirati Therapeutics
MRTX
#3041
Rank
NZ$7.01 B
Marketcap
$100.05
Share price
0.00%
Change (1 day)
53.06%
Change (1 year)

Mirati Therapeutics (MRTX) - Cash on Hand

Cash on Hand as of September 2023 : NZ$1.66 Billion

According to Mirati Therapeutics's latest financial reports the company has NZ$1.66 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mirati Therapeutics - Cash on Hand chart (from 2005 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$1.70 B-21.81%
2021-12-31NZ$2.18 B13.33%
2020-12-31NZ$1.92 B212.62%
2019-12-31NZ$0.61 B85.55%
2018-12-31NZ$0.33 B56.38%
2017-12-31NZ$0.21 B159.31%
2016-12-31NZ$81.9 M-54.17%
2015-12-31NZ$0.17 B377.9%
2014-12-31NZ$37.39 M-50.49%
2013-12-31NZ$75.53 M68.01%
2012-12-31NZ$44.95 M23.84%
2011-12-31NZ$36.3 M280.54%
2010-12-31NZ$9.53 M-58.44%
2009-12-31NZ$22.95 M-58%
2008-12-31NZ$54.66 M-31.72%
2007-12-31NZ$80.06 M-0.05%
2006-12-31NZ$80.1 M142.48%
2005-12-31NZ$33.03 M-31.58%
2004-12-31NZ$48.28 M32.09%
2003-12-31NZ$36.55 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.65 B-60.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.22 M-99.99% Bahamas